What are the indications for an echocardiogram (echo) in patients with bacteremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indications for Echocardiography in Bacteremia

Echocardiography should be performed in all patients with bacteremia who have high-risk features for infective endocarditis, with the specific organism and clinical context determining the urgency and modality (TTE vs TEE). 1

Mandatory Echocardiography Indications

High-Risk Organisms

  • Staphylococcus aureus bacteremia warrants echocardiography in nearly all cases due to the 25% risk of developing infective endocarditis and associated mortality of 25-46%. 1, 2, 3
  • Start with transthoracic echocardiography (TTE) as first-line imaging, though it has only 32-63% sensitivity for detecting endocarditis in S. aureus bacteremia. 2, 3
  • Transesophageal echocardiography (TEE) should follow if TTE is negative or non-diagnostic, as TEE increases sensitivity to 88-100% for detecting vegetations and complications. 2, 3

High-Risk Clinical Features (Any Organism)

  • Prosthetic heart valves or intracardiac devices (pacemakers, defibrillators) require TEE regardless of initial TTE findings, as these patients have a 16-32% risk of endocarditis. 1, 4, 2, 5
  • Persistent fever or bacteremia despite appropriate antibiotic therapy for 48-72 hours mandates repeat imaging to detect complications. 1, 2
  • New or changing cardiac murmur detected on examination requires immediate echocardiography. 1, 4
  • Embolic events (stroke, splenic infarct, peripheral emboli) indicate possible cardiac source and warrant urgent imaging. 1, 4
  • Signs of heart failure (new dyspnea, pulmonary edema, gallop rhythm) require echocardiography to assess valvular function and ventricular performance. 1, 4
  • Previous history of infective endocarditis significantly increases risk and mandates imaging. 4

Risk-Stratified Approach by Organism

Staphylococcus aureus Bacteremia

  • Community-acquired infection, prolonged bacteremia (>48 hours), or intracardiac prosthetic devices all require TEE after initial TTE. 6, 5
  • Very low-risk patients (nosocomial/line-related infection, no prosthetic valves/devices, bacteremia cleared within 48 hours, no clinical signs of endocarditis) may have echocardiography deferred with close clinical monitoring, as the yield is <5% in this subset. 7, 6, 5
  • However, even in low-risk patients, the absolute survival benefit of echocardiography is minimal (<0.5%), making clinical judgment paramount. 7

Other Gram-Negative Organisms (e.g., Enterobacter cloacae)

  • Not all bacteremias require routine echocardiography—individualized assessment based on high-risk features is appropriate for organisms other than S. aureus. 4
  • Order TTE initially if any high-risk features are present: prosthetic valves, intracardiac devices, persistent fever, new murmur, embolic events, heart failure, or immunocompromised status. 4
  • Elderly and immunocompromised patients may have atypical presentations with less prominent fever, requiring a lower threshold for imaging. 4

Echocardiography Protocol

Initial Imaging

  • TTE is the first-line modality with 70% sensitivity for native valve vegetations but only 50% for prosthetic valves. 1, 4
  • Perform TTE as soon as infective endocarditis is suspected, ideally within 24-48 hours of positive blood cultures in high-risk cases. 1

When to Proceed to TEE

  • TTE is negative but clinical suspicion remains high based on persistent fever, positive blood cultures, or high-risk organism. 1
  • TTE is non-diagnostic or suboptimal quality (obesity, COPD, mechanical ventilation). 1, 4
  • Prosthetic valve or intracardiac device is present, as TTE has poor sensitivity in these patients. 1, 4
  • TTE is positive for vegetations to evaluate for complications such as abscesses, perforations, or shunts that impact surgical decision-making. 1
  • Repeat TEE within 5-7 days if initial examination is negative but clinical suspicion remains high. 1

Reassessment During Treatment

Indications for Repeat Imaging

  • New complications develop: new murmur, embolic event, persistent fever, heart failure, atrioventricular block, or clinical deterioration. 1
  • Complex endocarditis (virulent organism like S. aureus, severe hemodynamic lesion, aortic valve involvement) warrants repeat imaging to monitor vegetation size and detect silent complications. 1

When Repeat Imaging is NOT Indicated

  • Uncomplicated native valve endocarditis with no regurgitation on baseline echocardiogram, responding well to antibiotics without clinical deterioration, new physical findings, or persistent fever does not require routine repeat TTE. 1

Common Pitfalls to Avoid

  • Do not rely solely on TTE in patients with prosthetic valves or intracardiac devices—TEE is mandatory as TTE sensitivity is only 50% in this population. 1, 4
  • Do not delay TEE in S. aureus bacteremia with negative TTE—19-21% of patients with negative or indeterminate TTE will have endocarditis detected on TEE. 3
  • Do not assume line-related bacteremia excludes endocarditis—while risk is lower, patients with prosthetic material or persistent symptoms still require imaging. 5
  • Do not order echocardiography for transient fever without bacteremia or new murmur—this is a Class III indication (not recommended). 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Echocardiography for Enterobacter cloacae Bacteremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prioritizing echocardiography in Staphylococcus aureus bacteraemia.

The Journal of antimicrobial chemotherapy, 2013

Research

Echocardiography has minimal yield and may not be warranted in Staphylococcus aureus bacteremia without clinical risk factors for endocarditis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.